The agreement was signed at the British Embassy in Kuwait by Rosemont Pharmaceuticals’ Head of International Sales, Mark Vallance and KSPICO’s Chairman and Managing Director Dr Rashed Khazal. Through this partnership, KSPICO will distribute a range of 'Rosemont' products in the GCC and Mena regions, including oral liquid formulations ranges and oral liquid medicines to support both pediatric and geriatric patients with swallowing difficulties.
Kuwait Saudi Pharmaceutical Industries Co., the leading national pharmaceutical manufacturer is launching IDREX spray for seasonal allergic rhino-sinusitis and Idrex inhalation solution for bronchial asthma in Kuwait.
Oxford Business Group (OBG) is dedicated to tracking how the most promising markets across Africa, the Middle East, Asia and Latin America are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues. Written by a team of dedicated researchers and regional editors that specialize in emerging markets, OBG research provides focused analysis on the implications for key sectors and the investment environment, drawing on our on-the-ground networks of experts and business leaders for informative insights.
Kuwait Saudi Pharmaceutical Industries Company’s 4 new production lines supported by the Italian "CSV - life science" Co.
Mezzan Holding KSCP enters a localization agreement with Abbott via its subsidiary, Kuwait Saudi Pharmaceutical Company, to localize manufacturing of 26 products in Kuwait
Kuwait Saudi Pharmaceutical Industries company (KSPICO) acquisition of ALSHIFA PHARMA.
Kuwait, November 14, 2020 - Mezzan Holding KSC, one of the Gulf region’s largest manufacturers and distributors of food and beverage, healthcare, and consumer products is proud to celebrate its 75th Year Anniversary this year. “This anniversary marks a significant milestone for Mezzan Holding whose origins date back to the 1940s before Kuwait’s ‘golden era’...